Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.000
+0.170 (4.44%)
Jan 28, 2026, 4:00 PM EST - Market closed

Camp4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22
208105--
Enterprise Value
139274--
Last Close Price
4.005.22--
PS Ratio
22.33161.17--
PB Ratio
3.201.66--
P/TBV Ratio
3.541.66--
EV/Sales Ratio
36.46420.77--
Debt / Equity Ratio
0.110.140.320.15
Asset Turnover
0.070.010.00-
Quick Ratio
9.526.684.9710.56
Current Ratio
9.836.925.1310.62
Return on Equity (ROE)
-172.70%-101.99%-80.13%-
Return on Assets (ROA)
-61.85%-49.80%-41.17%-
Return on Capital Employed (ROCE)
-67.90%-77.30%-110.10%-47.60%
Earnings Yield
-25.73%-49.29%--
FCF Yield
-22.97%-43.78%--
Buyback Yield / Dilution
-4278.53%-1087.44%-26.47%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q